Republished: Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosis.
| Autor: | Leader R; Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK rossleader@doctors.org.uk.; Acute Internal Medicine, University Hospital Aintree, Liverpool, UK., Cowen J; Accident and Emergency Medicine, University Hospital Aintree, Liverpool, UK., Rajeev SP; Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.; Diabetes & Endocrinology, University Hospital Aintree, Liverpool, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Drug and therapeutics bulletin [Drug Ther Bull] 2020 Apr; Vol. 58 (4), pp. 60-63. Date of Electronic Publication: 2019 Nov 29. |
| DOI: | 10.1136/dtb.2019.231104rep |
| Abstrakt: | Competing Interests: Competing interests: None declared. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|